ESLICARBAZEPINE ACETATE AS ADD-ON TREATMENT TO ANTIEPILEPTIC MONOTHERAPY IN ADULTS WITH PARTIAL-ONSET SEIZURES: REAL-WORLD DATA ON RETENTION, DOSING, PATIENT REPORTED SEIZURE OUTCOME AND SAFETY FROM AN INTERIM ANALYSIS OF THE OPEN-LABEL NON-INTERVENTIONAL STUDY EPOS